#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4419934	B	Inhibition of YAP1 (unknown origin) assessed as disruption in YAP1/OCT4 interaction by ELISA	Homo sapiens	33		single protein format	Patent Bioactivity Data
2.	ALA4419942	B	Inhibition of YAP1 in human NCI-H1650 cells assessed as disruption in YAP1/OCT4 interaction at 5 uM incubated for 72 hrs by immunoprecipitation-Westem blot assay	Homo sapiens	3		cell-based format	Patent Bioactivity Data
3.	ALA4419943	B	Inhibition of YAP1 in human A549 cells assessed as disruption in YAP1/OCT4 interaction at 5 uM incubated for 72 hrs by immunoprecipitation-Westem blot assay	Homo sapiens	3		cell-based format	Patent Bioactivity Data
4.	ALA4419944	B	Inhibition of YAP1 in human NCI-H1650 cells assessed as reduction in Sox2 protein expression at 5 uM by Western blot analysis	Homo sapiens	1		cell-based format	Patent Bioactivity Data
5.	ALA4419945	B	Inhibition of YAP1 in human A549 cells assessed as reduction in Sox2 protein expression at 5 uM by Western blot analysis	Homo sapiens	1		cell-based format	Patent Bioactivity Data
6.	ALA4419954	F	Inhibition of self-renewal capacity in stem-like side-population cells of human NCI-H1650 cells assessed as reduction in number of spheres at 1 to 20 uM incubated for 10 days by sphere formation assay	Homo sapiens	8		cell-based format	Patent Bioactivity Data
7.	ALA4419957	F	Cytotoxicity in human NCI-H1650 cells assessed as reduction in cell viability at 0.5 to 20 uM incubated for 72 hrs by MTT assay	Homo sapiens	3		cell-based format	Patent Bioactivity Data
8.	ALA4419958	F	Cytotoxicity in human A549 cells assessed as reduction in cell viability at 0.5 to 20 uM incubated for 72 hrs by MTT assay	Homo sapiens	3		cell-based format	Patent Bioactivity Data
9.	ALA4419963	B	Inhibition of YAP1 in human NCI-H1650 cells assessed as reduction in Sox2 protein expression at 5 uM by luciferase reporter gene assay	Homo sapiens	2		cell-based format	Patent Bioactivity Data
10.	ALA4419964	F	Inhibition of self-renewal capacity in stem-like side-population cells of human NCI-H1650 cells assessed as reduction in number of spheres at 5 uM incubated for 10 days by sphere formation assay relative to control	Homo sapiens	2		cell-based format	Patent Bioactivity Data
11.	ALA4419965	F	Cytotoxicity in human NCI-H1703 cells assessed as reduction in cell viability at 0.5 to 20 uM incubated for 96 hrs by MTT assay	Homo sapiens	3		cell-based format	Patent Bioactivity Data
12.	ALA4419966	F	Cytotoxicity in human NCI-H226 cells assessed as reduction in cell viability at 0.5 to 20 uM incubated for 96 hrs by MTT assay	Homo sapiens	3		cell-based format	Patent Bioactivity Data
13.	ALA4419969	F	Inhibition of adherence-independent cell growth in human NCI-H1650 cells at 5 uM incubated for 33 days	Homo sapiens	5		cell-based format	Patent Bioactivity Data
14.	ALA4419970	F	Inhibition of adherence-independent cell growth in human NCI-H1650 cells at 10 uM incubated for 33 days	Homo sapiens	5		cell-based format	Patent Bioactivity Data
15.	ALA4419974	F	Inhibition of self-renewal capacity in methotrexate insensitive stem-like side-population cells of human NCI-H146 cells assessed as reduction in number of spheres at 2 uM incubated for 3 days after 7 days methotrexate exposure by sphere formation assay	Homo sapiens	6		assay format	Patent Bioactivity Data
16.	ALA4419975	F	Cytotoxicity in erlotinib-resistant human HCC827 cells assessed as reduction in cell viability at 1 to 20 uM by MTT assay	Homo sapiens	3		cell-based format	Patent Bioactivity Data
17.	ALA4419976	F	Cytotoxicity in gefitinib resistant human PC9 cells assessed as reduction in cell viability at 1 to 20 uM by MTT assay	Homo sapiens	3		cell-based format	Patent Bioactivity Data
18.	ALA4419977	F	Cytotoxicity in gefitinib and erlotinib resistant human NCI-H1975 cells assessed as reduction in cell viability at 1 to 10 uM incubated for 72 hrs by MTT assay	Homo sapiens	5		cell-based format	Patent Bioactivity Data
19.	ALA4419978	B	Inhibition of YAP1 in human NCI-H1650 cells assessed as suppression of Sox2 mRNA expression at 5 to 10 uM incubated for 72 hrs by RT-PCR method	Homo sapiens	5		cell-based format	Patent Bioactivity Data
20.	ALA4419979	B	Inhibition of YAP1 in human NCI-H1703 cells assessed as suppression of Sox2 mRNA expression at 5 to 10 uM incubated for 72 hrs by RT-PCR method	Homo sapiens	5		cell-based format	Patent Bioactivity Data